Early research (Phase 1)Study completedNCT05181683
What this trial is testing
COVID-19 Study Assessing the Safety and Tolerability of Co-Formulated Anti-Spike (S) SARS-CoV-2 Monoclonal Antibodies (Casirivimab+Imdevimab) in Adult Volunteers
Who this might be right for
HealthyChronic Stable Illness
Regeneron Pharmaceuticals 45